Glucocorticoid‐induced hyperglycaemia in hospitalised adults: A matched cohort study (2013–2023)
Treatment with systemic glucocorticoids versus no glucocorticoid treatment during hospitalisation more than doubles the risk of new-onset hyperglycaemia. Higher age, weight, cumulative glucocorticoid dose, non-White ethnicity and autoimmune/inflammatory conditions were independently associated with a higher risk of GIH.
Authors
- Rishi Caleyachetty (ORCID: https://orcid.org/0000-0002-9282-7958)
- Rohini Mathur (ORCID: https://orcid.org/0000-0002-3817-8790)
- Rustam Rea (ORCID: https://orcid.org/0000-0001-6515-8325)
- Rajna Golubić (ORCID: https://orcid.org/0000-0003-0419-9582)
- Amanda Adler (ORCID: https://orcid.org/0000-0002-2797-3385)
- Ruth L. Coleman (ORCID: https://orcid.org/0000-0002-5194-8550)
- Hudson Mumbole
Institutions
- Queen Mary University of London (GB)
- University of Warwick (GB)
- University of Oxford (GB)
- Oxford Centre for Diabetes, Endocrinology and Metabolism (GB)
- Oxford University Hospitals NHS Trust (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1111/dom.16378
- Citations
- 6
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 7.77
Funders
- Action for Boston Community Development